Transmedics Group Inc’s filing revealed that its President & CEO Hassanein Waleed H acquired Company’s shares for reported $1.0 million on Aug 06 ’25. In the deal valued at $118.68 per share,8,400 shares were bought. As a result of this transaction, Hassanein Waleed H now holds 477,759 shares worth roughly $53.14 million.
Then, Hassanein Waleed H bought 8,475 shares, generating $985,209 in total proceeds. Upon buying the shares at $116.25, the President & CEO now owns 486,234 shares.
Before that, Basile Edward M sold 4,143 shares. Transmedics Group Inc shares valued at $519,988 were divested by the Director at a price of $125.51 per share. As a result of the transaction, Basile Edward M now holds 2,866 shares, worth roughly $0.32 million.
Jefferies initiated its Transmedics Group Inc [TMDX] rating to a Buy in a research note published on October 13, 2025; the price target was $145. A number of analysts have revised their coverage, including Evercore ISI’s analysts, who began to cover the stock in mid September with a ‘”an Outperform”‘ rating. Stifel began covering TMDX with “Hold” recommendation on September 04, 2025. JP Morgan revised its rating on December 17, 2024. It rated TMDX as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of TMDX
On Tuesday, Transmedics Group Inc [NASDAQ:TMDX] saw its stock fall -0.43% to $111.23. Over the last five days, the stock has lost -3.43%. Transmedics Group Inc shares have fallen nearly -18.15% since the year began. Nevertheless, the stocks have risen 78.40% over the past one year.
How much short interest is there in Transmedics Group Inc?
A steep rise in short interest was recorded in Transmedics Group Inc stocks on 2025-09-30, dropping by -0.13 million shares to a total of 8.14 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-29 was 8.27 million shares. There was a decline of -1.55%, which implies that there is a negative sentiment for the stock.
